289 related articles for article (PubMed ID: 30300032)
21. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
22. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
[TBL] [Abstract][Full Text] [Related]
23. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial.
Huang Q; Zeng Q; Long Y; Tan L; Zheng R; Xu E; Li K
Int J Hyperthermia; 2019; 36(1):1207-1215. PubMed ID: 31813295
[No Abstract] [Full Text] [Related]
24. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
[TBL] [Abstract][Full Text] [Related]
25. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ
J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287
[TBL] [Abstract][Full Text] [Related]
26. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma.
Liu Z; Wang X; Xing L; Pan Y; Huang S
Cancer Biother Radiopharm; 2019 Dec; 34(10):621-625. PubMed ID: 31809215
[No Abstract] [Full Text] [Related]
27. Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation.
Bo XW; Xu HX; Sun LP; Zheng SG; Guo LH; Lu F; Wu J; Xu XH
Int J Clin Exp Pathol; 2014; 7(9):6108-16. PubMed ID: 25337258
[TBL] [Abstract][Full Text] [Related]
28. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
[TBL] [Abstract][Full Text] [Related]
29. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma.
Zhong-Zhen S; Kai L; Rong-Qin Z; Er-Jiao X; Ting Z; Ao-Hua Z; Shu-Fang Y; Xu-Qi H
Ultraschall Med; 2012 Dec; 33(7):E250-E255. PubMed ID: 23238803
[TBL] [Abstract][Full Text] [Related]
30. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
[TBL] [Abstract][Full Text] [Related]
31. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P
Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound fusion imaging technologies for guidance in ablation therapy for liver cancer.
Minami Y; Kudo M
J Med Ultrason (2001); 2020 Apr; 47(2):257-263. PubMed ID: 32125577
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
34. [Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system].
Yuan CH; Xiu DR; Ge HY; Tan S; Wang HY; Zhang L; Zhang TL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):956-9. PubMed ID: 24343081
[TBL] [Abstract][Full Text] [Related]
35. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
Sugimoto K; Moriyasu F; Saito K; Kobayashi Y; Itoi T
J Med Ultrason (2001); 2017 Jul; 44(3):247-254. PubMed ID: 27933441
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound and cone beam CT fusion for liver ablation: technical note.
Monfardini L; Orsi F; Caserta R; Sallemi C; Della Vigna P; Bonomo G; Varano G; Solbiati L; Mauri G
Int J Hyperthermia; 2018; 35(1):500-504. PubMed ID: 30204007
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
Wang Y; Jing X; Ding J
Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.
Liu F; Yu X; Liang P; Cheng Z; Han Z; Dong B
Int J Hyperthermia; 2011; 27(6):555-62. PubMed ID: 21797695
[TBL] [Abstract][Full Text] [Related]
40. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M
Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
